Who owns NOVARTIS AG (NVS)? Elite investor 13F holders
9 tracked elite investors reported holding NOVARTIS AG as of 2026-06-30, including Dodge & Cox Funds, Renaissance Technologies LLC, GMO, Tweedy Browne, Maverick Capital. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
9 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Dodge & Cox Funds | NOVARTIS AG | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 119008937.00 USD | 759373.000000 | Shares | reduce | Original filing |
| Renaissance Technologies LLC | NOVARTIS AG | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 123500532.00 USD | 788033.000000 | Shares | reduce | Original filing |
| GMO | NOVARTIS AG | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 38546381.00 USD | 245957.000000 | Shares | reduce | Original filing |
| Tweedy Browne | NOVARTIS AG | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 11146710.00 USD | 71125.000000 | Shares | reduce | Original filing |
| Tudor Investment | NOVARTIS AG | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Maverick Capital | NOVARTIS AG | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4355092.00 USD | 27789.000000 | Shares | add | Original filing |
| Kahn Brothers Group | NOVARTIS AG | SHARE | 2026-06-30 | 2026-08-17 00:00:00 | 2066509.00 USD | 13186.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | NOVARTIS AG | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 420480.00 USD | 2683.000000 | Shares | hold | Original filing |
| Ancora Advisors / Ancora Holdings | NOVARTIS AG | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 326996.00 USD | 2086.000000 | Shares | reduce | Original filing |
| Causeway Capital Management | NOVARTIS AG | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 235168.00 USD | 1501.000000 | Shares | add | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.